BLC
IDXX icon

Brown, Lisle/Cummings’s Idexx Laboratories IDXX Stock Holding History

Brown, Lisle/Cummings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Buy
31
+29
+1,450% +$18.6K ﹤0.01% 492
2025
Q4 		$1.35K Hold
2
– – ﹤0.01% 671
2025
Q3 		$1.28K Hold
2
– – ﹤0.01% 685
2025
Q2 		$1.07K Hold
2
– – ﹤0.01% 703
2025
Q1 		$840 Buy
+2
New +$868 ﹤0.01% 723

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown, Lisle/Cummings's IDXX Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Idexx Laboratories (IDXX) stake by 1,450% in Q1 2026, buying an estimated $18.6K and bringing the position to 31 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Brown, Lisle/Cummings first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Brown, Lisle/Cummings held 31 shares of Idexx Laboratories worth $17.4K as of Q1 2026.
  • Brown, Lisle/Cummings bought 29 Idexx Laboratories shares in Q1 2026, an estimated $18.6K.
  • Idexx Laboratories made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #492 holding.
  • Brown, Lisle/Cummings first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.